Salix and Pharming Announce Extension of PDUFA Action Date for RUCONEST®

Salix and Pharming Announce Extension of PDUFA Action Date for RUCONEST®

[Business Wire] – Salix Pharmaceuticals, Ltd. and Pharming Group NV today announced that the Food and Drug Administration has extended the Prescription Drug User Fee Act Action Date to July 16, 2014 for the Company’s Biologics License Application for the more

View todays social media effects on SLXP

View the latest stocks trending across Twitter. Click to view dashboard

See who Salix is hiring next, click here to view

Share this post